US Broker Ratings

ImmunityBio, Inc. (IBRX): Harnessing a 407% Revenue Growth with a Promising 28% Upside Potential

ImmunityBio, Inc. (NASDAQ: IBRX), a pioneering player in the biotechnology sector, has been capturing investor attention with its robust revenue growth and promising stock performance. The company, headquartered in San..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Exploring a 7.68% Potential Upside

For investors considering the healthcare sector, Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents an intriguing opportunity. As a major player in providing behavioral healthcare services across the United States and..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Unveiling a 12.8% Potential Upside in Biotech Innovation

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning biotechnology firm based in Switzerland, is making waves in the healthcare sector with its promising portfolio of treatments targeting inflammatory diseases. With a market..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Potential 94% Upside Lures Investors

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a biotechnology firm with a focus on rare endocrine diseases, is catching the eye of investors with its significant potential upside. Based in San Diego,..

Arcellx, Inc. (ACLX) Stock Analysis: Navigating Biotech Volatility with Strong Analyst Support

Arcellx, Inc. (NASDAQ: ACLX) is capturing the attention of investors in the biotech sector with its innovative immunotherapy developments. Headquartered in Redwood City, California, Arcellx focuses on creating treatments for..

Sotera Health Company (SHC) Stock Analysis: A 16.85% Potential Upside in Healthcare Diagnostics & Research

Sotera Health Company (NASDAQ: SHC) stands out in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $4.97 billion, the company has established itself..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 50% Upside Potential in Biotech

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the biotechnology sector with a market capitalization of $4.69 billion, making it an intriguing prospect for investors seeking exposure to the healthcare..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: A Potential 30.79% Upside in the Healthcare Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector, specializes in the development of innovative medical devices, particularly for patients suffering from obstructive sleep apnea (OSA)...

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring a 41.94% Potential Upside Amidst Strong Buy Ratings

Nuvalent, Inc. (NASDAQ: NUVL) is drawing significant attention in the biotechnology sector with its promising pipeline and robust analyst support. The clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, is focused..

BrightSpring Health Services (BTSG): Analyst Consensus Reveals Strong Buy Ratings and 8.3% Upside Potential

BrightSpring Health Services, Inc. (BTSG), a formidable player in the U.S. healthcare market, operates within the Health Information Services industry. With a market capitalization of $7.41 billion, the company has..

Legend Biotech Corporation (LEGN): Analyst Consensus Highlights 248% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN), a dynamic player in the biotechnology sector, is drawing attention with its significant potential upside of 248.08%, as revealed by recent analyst ratings. As a..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring Growth Potential Amidst 434% Revenue Surge

Avidity Biosciences, Inc. (NASDAQ: RNA) is capturing the attention of investors with its remarkable 434% revenue growth, underscoring its potential in the burgeoning biotechnology sector. As a biopharmaceutical company specializing..

Sarepta Therapeutics, Inc. (SRPT): Investor Outlook on Promising Gene Therapy Potential and 13.53% Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands at the forefront of the biotechnology sector with its innovative RNA-targeted therapeutics and gene therapies aimed at treating rare diseases like Duchenne muscular dystrophy...

Viatris Inc. (VTRS) Investor Outlook: Navigating a 3.02% Dividend Yield Amidst Healthcare Opportunities

For individual investors eyeing the healthcare sector, Viatris Inc. (NASDAQ: VTRS) presents an intriguing case. With a market capitalization of $18.38 billion, Viatris operates as a major player in the..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 27% Upside Potential with Robust Growth Prospects

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is capturing investor attention with a promising upside potential of 27.42%. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals is..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 42.11% Upside Potential with a Strong Buy Consensus

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands out in the biotechnology sector, capturing investor attention with its focus on rare neuroendocrine diseases. Headquartered in Boston, Massachusetts, this commercial-stage biopharmaceutical company is..

Halozyme Therapeutics (HALO) Stock Analysis: Strong Revenue Growth and Significant Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to drug delivery and impressive financial metrics. With a market..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a 16.4% Potential Upside Amidst Market Volatility

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company, presents a compelling opportunity for investors who are keen to explore the evolving landscape of healthcare plans in the United States...

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling a 73% Potential Upside in the Healthcare Sector

For investors with an eye for opportunity in the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) presents a compelling case. Headquartered in Italy, this company operates within the medical instruments..

Henry Schein, Inc. (HSIC) Stock Analysis: A Comprehensive Look at Growth Potential Amidst Healthcare Distribution Dynamics

Henry Schein, Inc. (NASDAQ: HSIC), a prominent player in the medical distribution sector, has carved out a significant niche by providing a wide array of healthcare products and services. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds